Browse Arkansas Code titles and sections
4-117-101. Definitions.
Arkansas Code — all titles (historical 2020) · legal_authorities
4-117-101. Definitions.
As used in this chapter:
(1) “Authorized distributors of record” means those distributors with whom a drug manufacturer has established an ongoing relationship to distribute the drug manufacturer's products;
(2) “Board” means the Arkansas State Board of Pharmacy;
(3)(A) “Distribute” means the distribution of drug samples.
(B) “Distribute” does not include the providing of a drug sample to a patient by a:
(i) Physician or practitioner licensed to prescribe the drug;
(ii) Health care professional acting at the direction and under the supervision of a physician or practitioner; or
(iii) Pharmacy that has been granted approval from the Arkansas State Board of Pharmacy to handle samples at the direction of a physician or practitioner and that received the sample under this chapter;
(4) “Drug” means all medicines and preparations recognized in the United States Pharmacopoeia or the National Formulary as substances intended to be used for the care, mitigation, or prevention of disease of either humans or other animals;
(5) “Drug sample” means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug;
(6) “Licensed pharmacist” means a person holding a license under § 17-92-101 et seq.;
(7) “Pharmacy” means the place licensed by the board in which drugs, chemicals, medicines, prescriptions, and poisons are compounded, dispensed, or sold at retail; and
(8) “Physician” means a practitioner of medicine licensed under the laws of this state or some other state.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 4-117-101
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:4-117-101
Source file: gov.ar.code.title.04.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 1c11fb5eb31e4d02acaa6bfd8c1a211936958487269a10e0c7207bdb57983fda
Source location: content.xml paragraph 38964
Stored source content
4-117-101. Definitions.
As used in this chapter:
(1) “Authorized distributors of record” means those distributors with whom a drug manufacturer has established an ongoing relationship to distribute the drug manufacturer's products;
(2) “Board” means the Arkansas State Board of Pharmacy;
(3)(A) “Distribute” means the distribution of drug samples.
(B) “Distribute” does not include the providing of a drug sample to a patient by a:
(i) Physician or practitioner licensed to prescribe the drug;
(ii) Health care professional acting at the direction and under the supervision of a physician or practitioner; or
(iii) Pharmacy that has been granted approval from the Arkansas State Board of Pharmacy to handle samples at the direction of a physician or practitioner and that received the sample under this chapter;
(4) “Drug” means all medicines and preparations recognized in the United States Pharmacopoeia or the National Formulary as substances intended to be used for the care, mitigation, or prevention of disease of either humans or other animals;
(5) “Drug sample” means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug;
(6) “Licensed pharmacist” means a person holding a license under § 17-92-101 et seq.;
(7) “Pharmacy” means the place licensed by the board in which drugs, chemicals, medicines, prescriptions, and poisons are compounded, dispensed, or sold at retail; and
(8) “Physician” means a practitioner of medicine licensed under the laws of this state or some other state.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Arkansas Code — all titles (historical 2020) · legal_authorities
17-92-101. Definitions.
As used in this chapter:
(1) “Biological product” means a biological product as defined by 42 U.S.C. § 262(i)(1), as it existed on January 1, 2019;
(2) “Credentialing” means the issuance of or approval by the Arkansas State Board of Pharmacy of a credential issued to a pharmacist by an agency approved by the Arkansas State Board of Pharmacy certifying that the pharmacist has met the standards of competency established by the Arkansas State Board of Pharmacy for disease state management or other pharmacy services necessitating a credential;
(3) “Dentist” means a practitioner of dentistry duly licensed under the laws of this or some other state;
(4)(A) “Disease state management” means a strategy that utilizes a team-oriented, multidisciplinary approach to improve healthcare outcomes and quality of care, and when possible, to control healthcare cost through management of targeted chronic disease states.
(B) Disease state management focuses on improving health care from prevention to diagnosis and treatment to ongoing follow-up.
(C) Disease state management will involve, but not be limited to, patient education, self-care techniques, and outpatient drug therapy management pursuant to a patient care plan;
(5) “Drug” shall include all medicines and preparations recognized in the United States Pharmacopeia or the National Formulary as substances intended to be used for the care, mitigation, or prevention of disease of either man or other animals;
(6) “Generically equivalent” means a drug that is pharmaceutically and therapeutically equivalent to the drug prescribed;
(7) “Interchangeable biological product” means a biological product that is interchangeable as defined by 42 U.S.C. § 262(i)(3), as it existed on January 1, 2019;
(8)(A)
Source: Arkansas Code — historical release 78 (November 6, 2020) · 17-92-101
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. The source passage cites 17-92-101. This identifies an authority to review, not proof of applicability.